EXELA
Welcome to the Brand page for “EXELA”, which is offered here for The mark consists of a container with a stirrer together with the words exela in an oval shape in the middle of the container.;in the statement, line 9 after disorders, excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer is inserted.;pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, * excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer *;color is not claimed as a feature of the mark.;product development consulting in the field of developing pharmaceutical products in specialized dosage forms, controlled drug-releasing formulations, sterile products, topical products, and attendant analytical services;.
Its status is currently believed to be active. Its class is unavailable. “EXELA” is believed to be currently owned by “EXELA HOLDINGS, INC.”
| Owner: |
EXELA HOLDINGS, INC.
Owner Details |
|---|---|
| Description: |
The mark consists of a container with a stirrer together with the words EXELA in an oval shape in the middle of the container.;In the statement, line 9 after disorders, excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer is inserted.;Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, * excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer *;Color is not claimed as a feature of the mark.;Product development consulting in the field of developing pharmaceutical products in specialized dosage forms, controlled drug-releasing formulations, sterile products, topical products, and attendant analytical services;
|
| Categories: |
